- Filed
- Apr 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Cash And Equivalents | FY 2024 · Dec 31, 2024 | $27.44K |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $179.01K |
| Stockholders Equity | FY 2024 · Dec 31, 2024 | $3.19M |
| Stockholders Equity | FY 2024 · Dec 31, 2023 | $12.23M |
| Net Income | FY 2024 · Dec 31, 2024 | −$11.22M |
| Net Income | FY 2024 · Dec 31, 2023 | −$23.18M |
| Shares Diluted restated | FY 2024 · Dec 31, 2023 | 1.52M sh |
| Capex | FY 2024 · Dec 31, 2023 | $1.23M |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | $2.05M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $7.23M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $7.38M |
| Current Assets | FY 2024 · Dec 31, 2023 | $1.82M |
| Total Assets | FY 2024 · Dec 31, 2023 | $19.73M |
| Eps Diluted restated | FY 2024 · Dec 31, 2023 | −$15.33 |
| Eps Basic restated | FY 2024 · Dec 31, 2023 | −$15.33 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $7.08M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$23.48M |
| Revenue | FY 2024 · Dec 31, 2023 | $30.57M |